Has Faraz Ahmad Khan Daha, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,072 in general payments to Faraz Ahmad Khan Daha, MD across 65 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Faraz Ahmad Khan Daha, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Faraz Ahmad Khan Daha, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Faraz Ahmad Khan Daha, MD

Interventional Pain Medicine · Kenosha, WINPI 1235545534

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Medtronic at 28.9% of the total. Reporting peaked in 2019 at $1,982 and has fallen 98.1% since, to $38 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in WI, where the typical reported total is $2,684.

$3,072in general payments, 2019–2025

Across 65 payments — averaging $47.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$887
Boston Scientific$821
Abbott$653
Nevro Corp.$284
Si-bone, Inc.$119
SPR Therapeutics, Inc$58
plus $249 from 9 others

What the payments were for

Food & beverage$3,05699%
Education$161%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	16	$887
Boston Scientific	10	$821
Abbott	18	$653
Nevro Corp.	5	$284
Si-bone, Inc.	1	$119
SPR Therapeutics, Inc	1	$58
Biodelivery Sciences International, Inc.	3	$46
Amgen	2	$44
Pfizer	3	$40
Ipsen Biopharmaceuticals, Inc	1	$26
Stimwave Technologies Incorporated	1	$24
Teva Pharmaceuticals USA, Inc.	1	$22
Novartis	1	$18
Stryker	1	$16
Lundbeck LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPECTRA WAVEWRITER$391
GENERAL PAIN MANAGEMENT$223
Penta SCS Leads$155
Senza Spinal Cord Stimulation System$140
INTELLIS$130
iFuse Implant$119
RESTORE$119
Proclaim Family of SCS IPGs$104

How this compares

$3,072 in reported general payments places this provider in the 50th percentile of 41 interventional pain medicine providers in Wisconsin.

See all interventional pain medicine providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$46,870

Medicare patients

129

Services billed

583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pregabalin	67	$1,859
Gabapentin	169	$1,792
Naloxone Hcl	27	$1,588
Celecoxib	16	$667
Tizanidine Hcl	90	$552
Baclofen	54	$502
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	21	$442
Cyclobenzaprine Hcl	51	$303
Methylprednisolone	56	$302
Duloxetine Hcl	22	$285
Diclofenac Sodium	17	$139
Tramadol Hcl	54	$112
Acetaminophen-CodeineAcetaminophen With Codeine	22	$83
Alprazolam	38	$28

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Kenosha

Timothy StaackeKenosha$13K
Alexandra LelchukKenosha$9K
Hardik VashiKenosha$5K
Christopher HowsonGreen Bay$114K
Matthew PileckiMount Pleasant$29K
Christina MooreMilwaukee$26K
Nileshkumar PatelGreenfield$25K
Daniel BrunnerNeenah$24K
Vishal Patelde Pere$23K
Colin StairSummit$17K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →